Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

fool.com - Sara Appino - Which Healthcare ETF Is the Better Buy: Simplify's Active PINK or VanEck's Pharma-Focused PPH?
Which Healthcare ETF Is the Better Buy: Simplify's Active PINK or VanEck's Pharma-Focused PPH?
The Motley Fool –

The Simplify Health Care ETF (PINK +2.58%) provides active management and broad sector exposure, while the VanEck Pharmaceutical ETF (PPH +1.20%) offers a lower-cost, concentrated index of global pharmaceutical leaders. Investors seeking healthcare…

marketbeat.com - Nuvectis Pharma (NASDAQ:NVCT) Shares Gap Up - What's Next?
Nuvectis Pharma (NASDAQ:NVCT) Shares Gap Up - What's Next?
MarketBeat –

Nuvectis Pharma, Inc. (NASDAQ:NVCT - Get Free Report)'s stock price gapped up prior to trading on Monday. The stock had previously closed at $20.13, but opened at $21.12. Nuvectis Pharma shares last traded at $21.20, with a volume of 1,499 shares…

marketbeat.com - Urogen Pharma (NASDAQ:URGN) Stock Has Consensus Price Target of $52.38 According to Analysts
Urogen Pharma (NASDAQ:URGN) Stock Has Consensus Price Target of $52.38 According to Analysts
MarketBeat –

Shares of Urogen Pharma (NASDAQ:URGN - Get Free Report) have been given an average recommendation of 'Moderate Buy' by the ten brokerages that are presently covering the stock, Marketbeat reports. One research analyst has rated the stock with a…

medpagetoday.com - Charles Bankhead - Drug-Eluting Intraocular Lens Passes Test in Patients With Cataracts and Glaucoma
Drug-Eluting Intraocular Lens Passes Test in Patients With Cataracts and Glaucoma
Medpage Today –

NEW ORLEANS -- An intraocular lens (IOL) packed with glaucoma medication showed early promise as a potential treatment for cataract and glaucoma in randomized comparison against standard glaucoma therapy. The bimatoprost drug pad-intraocular lens…

seekingalpha.com - High Alpha Professor - Nordic American Tankers: Grab That 13% Yield While The Tanker Boom Lasts (NYSE:NAT)
Nordic American Tankers: Grab That 13% Yield While The Tanker Boom Lasts (NYSE:NAT)
Seeking Alpha –

Nordic American Tankers is rated Buy, driven by surging tanker rates, strong recent fixtures, and an attractive—though variable—dividend yield near 13%. Recent fixtures averaged $96,800/day, far above Q2's $63,000/day, but…

thehindubusinessline.com - Agilisium eyes topline of $0.5 billion in 5-7 years
Agilisium eyes topline of $0.5 billion in 5-7 years
BusinessLine –

Agilisium, a life science-focused technology services firm has set itself a target of $0.5 billion in revenues by the next five to seven years. The ambitious topline target comes at a time when the company, which has a large presence in Chennai…

seekingalpha.com - Steven Cress - Top Healthcare Stocks: Playing Offense And Defense For The Win
Top Healthcare Stocks: Playing Offense And Defense For The Win
Seeking Alpha –

Healthcare offers investors a potential combination of offense with forward earnings and defense with rising demand amid persistent macro-economic uncertainty. The healthcare sector is positioned for above-average long-term growth, supported by…

seekingalpha.com - Albert Anthony - Wynn Resorts Is A Buy As Global Hotel/Casino Portfolio Shows Resilience (NASDAQ:WYNN)
Wynn Resorts Is A Buy As Global Hotel/Casino Portfolio Shows Resilience (NASDAQ:WYNN)
Seeking Alpha –

Albert Anthony is the pen name of a business author on Amazon and his newest book is 'How To Pick Stocks: 8 Steps For Long-Term Investing with Fundamental & Technical Analysis,' now available as a 2026 edition paperback and Kindle ebook in several…

koreatimes.co.kr - Lee Kyung-min - HLB resubmits FDA application for liver cancer treatment
HLB resubmits FDA application for liver cancer treatment
The Korea Times –

Korean drugmaker HLB has resubmitted its application for U.S. approval of a combination therapy for advanced liver cancer, renewing its push to bring the target treatment to market after addressing regulatory concerns raised earlier this year. The…

thehindubusinessline.com - Early gains wiped out: Nifty slides below 22,400 as IT, FMCG and banking drag markets lower
Early gains wiped out: Nifty slides below 22,400 as IT, FMCG and banking drag markets lower
BusinessLine –

Equity benchmarks reversed their early gains sharply by mid-session on Monday, with the Nifty 50 falling 160.95 points or 0.71 per cent to 22,359.50 and the Sensex dropping 599.44 points or 0.83 per cent to 71,872.89 as of 13.15 pm. Both indices…

marketbeat.com - Teva Pharmaceutical Industries (NYSE:TEVA) Stock Price Target Raised at JPMorgan Chase & Co.
Teva Pharmaceutical Industries (NYSE:TEVA) Stock Price Target Raised at JPMorgan Chase & Co.
MarketBeat –

Teva Pharmaceutical Industries (NYSE:TEVA - Get Free Report) had its price target raised by JPMorgan Chase & Co. from $40.00 to $50.00 in a report released on Monday, Benzinga reports. The brokerage currently has an 'overweight' rating on the…

rediff.com - Subrata Panda - HSBC leads global banks in facilitating Indian corporate fundraising across bonds, loans, and IPOs
HSBC leads global banks in facilitating Indian corporate fundraising across bonds, loans, and IPOs
Rediff.com –

HSBC has solidified its position as the premier international bank for Indian corporate fundraising, leading across G3 bonds, syndicated loans, and initial public offerings in the January-September 2026 period. HSBC was the leading international…

thehindubusinessline.com - KS Badri Narayanan - Stock Market Today Highlights: Stock markets tumble on oil price spike, foreign fund outflows; Sensex drops 548 points
Stock Market Today Highlights: Stock markets tumble on oil price spike, foreign fund outflows; Sensex drops 548 points
BusinessLine –

Sensex Today, Nifty 50 | Stock Market Highlights: Erasing opening gains, the 30-share BSE Sensex tanked 547.65 points, or 0.76%, to settle at 71,924.68. The 50-share NSE Nifty dropped 157.10 points, or 0.70%, to end at 22,363.35. From the 30 Sensex…

thehindubusinessline.com - Rupee gains 96 paise, but Nifty falls 157 points on crude, FII outflows
Rupee gains 96 paise, but Nifty falls 157 points on crude, FII outflows
BusinessLine –

Indian equities closed lower on Monday as elevated crude oil prices, persistent foreign fund outflows and rising bond yields weighed on sentiment, offsetting the rupee's sharp appreciation against the US dollar. The Nifty 50 fell 157.10 points, or…

thehindubusinessline.com - Nifty holds flat at open despite Wall Street gains; FII selling streak hits 11 sessions
Nifty holds flat at open despite Wall Street gains; FII selling streak hits 11 sessions
BusinessLine –

Equity benchmarks opened on a cautious note on Monday with the Nifty 50 opening at 22,593.20 against a previous close of 22,520.45, and trading near 22,525.60, up just 5.15 points or 0.02 per cent, at 9.25 am. The Sensex opened at 72,771.32…

Receive a Daily briefing on Pharma Industry News

Get Started